These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2727575

  • 1. [Motor fluctuations in Parkinson's disease: the "New frontier" of therapeutic success. A Roche Laboratory seminar].
    d'Anglejan Chatillon J.
    Rev Prat; 1989 Mar 09; 39(8):689-90. PubMed ID: 2727575
    [No Abstract] [Full Text] [Related]

  • 2. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].
    Fernández Pardal MM, Gatto E, Micheli F, Casas Parera I, Diaz S.
    Medicina (B Aires); 1991 Mar 09; 51(6):561-7. PubMed ID: 7476112
    [Abstract] [Full Text] [Related]

  • 3. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI, Mark MH.
    Ann Neurol; 1991 Oct 09; 30(4):616-7. PubMed ID: 1789688
    [Abstract] [Full Text] [Related]

  • 4. (-)Deprenyl in the treatment of decompensated Parkinson's disease.
    Csanda E, Tárczy M, Takáts A.
    J Neural Transm Suppl; 1986 Oct 09; 22():247-52. PubMed ID: 3097259
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
    Poewe WH, Lees AJ, Stern GM.
    Eur Neurol; 1987 Oct 09; 27 Suppl 1():93-7. PubMed ID: 3322842
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
    Ruggieri S, Carta A, Stocchi F, Antonini A, Bellantuono P, Monge A.
    Funct Neurol; 1988 Oct 09; 3(4):471-9. PubMed ID: 3072281
    [No Abstract] [Full Text] [Related]

  • 7. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA, Gachoud JP.
    Praxis (Bern 1994); 1995 Oct 24; 84(43):1235-8. PubMed ID: 7481341
    [Abstract] [Full Text] [Related]

  • 8. [Drug therapy of Parkinson's disease].
    Zhou XD.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 24; 18(4):193-6. PubMed ID: 4075905
    [No Abstract] [Full Text] [Related]

  • 9. Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
    Prakash KM, Kek PC.
    Parkinsonism Relat Disord; 2010 Dec 24; 16(10):691-2. PubMed ID: 20729126
    [No Abstract] [Full Text] [Related]

  • 10. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB, Suchowersky O, Purves S, Calne S, Calne DB.
    Clin Neuropharmacol; 1986 Dec 24; 9(2):196-9. PubMed ID: 3708604
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O, von Schéele C.
    Pharmacotherapy; 1997 Dec 24; 17(5):1027-30. PubMed ID: 9324193
    [Abstract] [Full Text] [Related]

  • 12. Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.
    Contin M, Riva R, Martinelli P, Cortelli P, Albani F, Baruzzi A.
    Clin Neuropharmacol; 1999 Dec 24; 22(6):351-5. PubMed ID: 10626097
    [Abstract] [Full Text] [Related]

  • 13. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM, Juncos JL, Fabbrini G, Chase TN.
    Ann Neurol; 1987 Oct 24; 22(4):475-9. PubMed ID: 3435068
    [Abstract] [Full Text] [Related]

  • 14. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S, Fabbrini G, Bramante L, DePandis F, Stocchi F, Barbanti P, Vacca L, Manfredi M.
    Adv Neurol; 1996 Oct 24; 69():595-8. PubMed ID: 8615185
    [No Abstract] [Full Text] [Related]

  • 15. Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations.
    Quinn NP, Marion MH, Marsden CD.
    Eur Neurol; 1987 Oct 24; 27 Suppl 1():105-13. PubMed ID: 3322834
    [Abstract] [Full Text] [Related]

  • 16. [Parkinson's disease and pregnancy: case report and literature review].
    Routiot T, Lurel S, Denis E, Barbarino-Monnier P.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep 24; 29(5):454-7. PubMed ID: 11011274
    [Abstract] [Full Text] [Related]

  • 17. Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
    Kurtis MM, Franch O.
    Parkinsonism Relat Disord; 2011 Dec 24; 17(10):774-6. PubMed ID: 21733737
    [No Abstract] [Full Text] [Related]

  • 18. Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
    Lees AJ.
    Adv Neurol; 1990 Dec 24; 53():475-82. PubMed ID: 2239487
    [No Abstract] [Full Text] [Related]

  • 19. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
    Wenning GK, Bösch S, Luginger E, Wagner M, Poewe W.
    Adv Neurol; 1999 Dec 24; 80():545-8. PubMed ID: 10410769
    [No Abstract] [Full Text] [Related]

  • 20. Medical management of motor fluctuations.
    Dewey RB.
    Neurol Clin; 2008 Aug 24; 26(3 Suppl):S15-27, v. PubMed ID: 18774440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.